First cohort final safety data gets announced 28 days after first dosing that starts in next 3-4 weeks. Big milestone. 60 million market cap, based off other drugs targeting similar indications 80-100 million market cap on safety clearance. The drug will be taken over either way, I’m more interested in the cardiovascular protection indication
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)